Karuna Therapeutics, Inc.
KRTXDelisted Mar 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771917
Karuna Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 18, 2024; 328 institutions reported holding it in 13F filings for Q4 2023, worth $12.0B in total; no superinvestor held it.
Holders of 5% or more of KRTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Karuna Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Karuna Therapeutics, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Karuna Therapeutics, Inc., newest first.
No Schedule 13D or 13G filings on Karuna Therapeutics, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Karuna Therapeutics, Inc. shares.
No Form 144 notices for Karuna Therapeutics, Inc. are on file.